Article
Inhibiting MARSs reduces hyperhomocysteinemia‐associated neural tube and congenital heart defects
31 Jan 2020
Abstract excerpt
Hyperhomocysteinemia is a common metabolic disorder that imposes major adverse health consequences. Reducing homocysteine levels, however, is not always effective against hyperhomocysteinemia-associated pathologies. Herein, we report the potential roles of methionyl-tRNA synthetase (MARS)-generated homocysteine signals in neural tube defects (NTDs) and congenital heart defects (CHDs). Increased copy numbers of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
